Both present with clinically significant sleep disturbance; the substance/medication-induced form requires a demonstrated etiological link to a specific agent and severity in excess of that agent's typical effect, while Insomnia Disorder is an independent sleep disorder.
Substance/medication-induced sleep disturbance tracks intoxication, withdrawal, or medication exposure within a tight timeframe; Insomnia Disorder requires difficulty at least 3 nights per week for at least 3 months, without needing a substance trigger.
Substance/medication-induced sleep disturbance is expected to improve as the agent clears or is adjusted; Insomnia Disorder persists independently and meets its own duration threshold.
Substance/medication-induced presentations often track the specific agent's known sleep effects (e.g., stimulant-related insomnia, sedative-related hypersomnia); Insomnia Disorder shows the classic sleep-onset or maintenance difficulty pattern without a substance explanation.
Both can significantly impair daytime functioning, concentration, and mood; impairment severity alone does not distinguish which etiology is responsible.
An independent Insomnia Disorder, Hypersomnolence Disorder, or Narcolepsy occurring apart from substance/medication use must be ruled out, and the disturbance must be more severe than what's typically expected from that substance/medication alone.
The key differential question is whether the sleep disturbance is more severe than what's typically expected from a specific substance or medication's ordinary effect, with a timeline that fits, versus reflecting an independent, persistent sleep disorder.
Any sleep trouble in someone taking a sleep-affecting medication is sometimes assumed to automatically qualify as substance/medication-induced; the disturbance must actually be severe enough to be a distinct focus of clinical attention, beyond the substance's ordinary, expected effect.
Severe, persistent insomnia beginning shortly after starting a stimulant medication, well beyond its typical mild sleep-onset delay, resolving with dose adjustment, points to the induced form; chronic difficulty falling or staying asleep 3+ nights weekly for 3+ months with no substance link points to Insomnia Disorder.
| Feature | Substance/Medication-Induced Sleep Disorder | Insomnia Disorder |
|---|---|---|
| Etiological trigger | Substance/Medication-Induced: specific agent identified with known sleep effects | Insomnia Disorder: no substance/medication requirement |
| Severity relative to substance's typical effect | In excess of ordinary, expected effect | N/A — independent disorder |
| Duration threshold | Tracks substance exposure/clearance | At least 3 nights/week for at least 3 months |
A prominent and severe disturbance of sleep that developed during or soon after substance intoxication or withdrawal, or after exposure to a medication capable of producing sleep disturbance, where the substance/medication is judged etiologically related to the disturbance and the sleep disturbance is severe enough to warrant independent clinical attention.
Predominant dissatisfaction with sleep quantity or quality, with difficulty initiating sleep, difficulty maintaining sleep, or early-morning awakening with inability to return to sleep, occurring at least 3 nights per week for at least 3 months, causing clinically significant distress or impairment, despite adequate opportunity for sleep.